Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Prostatic Neoplasms 5Carcinoma, Hepatocellular 4Parathyroid Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Liver Diseases 1Hyperparathyroidism, Primary 1Disease 1Breast Neoplasms 1

Interventions

Cinacalcet 3belinostat 2Trastuzumab 2Nivolumab 2Denosumab 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1fluorodopa F 18 1fluorocholine 1evocalcet 1entinostat 1acetaminophen, codeine drug combination 1Tramadol 1Tablets 1Standard of Care 1Specimen Handling 1Sodium Chloride 1Ritonavir 1Radiotherapy 1Parathyroidectomy 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Gefitinib 1Fluorouracil 1Dacarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Parathyroid Neoplasms × fluorocholine × Clear all
NCT07444723 2026-05-12

Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2/3 Recruiting
193 enrolled
EndocrineHead & Neck

Parathyroid Neoplasms, Multiple Endocrine Neoplasia Type 1, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡